![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/343 | |
A61P 5/00 | |||
A61P 43/00 | |||
A61K 45/06 | |||
A61K 31/31 | |||
A61K 31/496 | |||
G16H 10/60 |
(11) | Number of the document | 2934509 |
(13) | Kind of document | T |
(96) | European patent application number | 13817826.4 |
Date of filing the European patent application | 2013-12-18 | |
(97) | Date of publication of the European application | 2015-10-28 |
(45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/076311 |
Date | 2013-12-18 |
(87) | Number | WO 2014/100292 |
Date | 2014-06-26 |
(30) | Number | Date | Country code |
201261738985 P | 2012-12-18 | US | |
201261738987 P | 2012-12-18 | US | |
201361755896 P | 2013-01-23 | US | |
PCT/US2013/0233 | 2013-01-25 | WO | |
201313751011 | 2013-01-25 | US | |
201361903354 P | 2013-11-12 | US |
(72) |
DRESSMAN, Marlene Michelle, US
FEENEY, John Joseph, US
LICAMELE, Louis William, US
POLYMEROPOULOS, Mihael H., US
|
(73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue NW Suite 300, Washington, DC 20037,
US
|
(54) | TASIMELTEON FOR THE TREATMENT OF CIRCADIAN RHYTHM DISORDERS |
TASIMELTEON FOR THE TREATMENT OF CIRCADIAN RHYTHM DISORDERS |